← FDA Drug Approvals (Drugs@FDA)
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2025-06-27
Drug application
- FDA Application #
ANDA219199- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
- Generic name
- DOXORUBICIN HYDROCHLORIDE
- Active ingredients
- DOXORUBICIN HYDROCHLORIDE
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ALEMBIC
- Manufacturer
- Alembic Pharmaceuticals Limited
- First approval
- 2025-06-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown